Quinazolinone novel derivatives synthesis and their Biological Evaluation as Antimicrobial and Antitubercular agents

Neha Krishnarth (1) , Santosh Kumar Verma (2) , Anurag (3)
(1) Dr. K. N Modi Institute of Pharmaceutical Education and Research, Old Cloth Mill Compound, Opposite to S .B. I Main Branch, Modinagar-201201, India, India ,
(2) Faculty of Pharmaceutical Sciences, Motherhood University, Vill. Karoundi, Dehradun Road, P.O. Bhagwanpur, Roorkee, District, Haridwar (Uttrakhand)-247661, India, India ,
(3) Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Baghpat Crossing, NH-58, Bypass Road, Meerut-250005, India, India

Abstract

At a global level, tuberculosis (TB) is the disease of human values. It suffers from major health, social and economic burden in many countries. There is an inability of an effective vaccine or the use of vaccine were too long and expensive, have increased risk of spread of this disease. A series of quinazolinone derivatives prepared with the help of 2-Amino-3,4,5-trimethoxy benzoic acid and Vilsmeir reagent. Synthesized compounds were characterized by various spectral methods. Different activity like antimicrobial activity of the synthesised compounds were performed, and the most active compounds of the series were further screened for antitubercular activity against bacteria mycobacterium H37Rv. Results showed that all the synthesized compounds have antimicrobial activity. Compounds IV c, IV f, IV h and IV o showed maximum activity in the synthesized series. These four compounds further screened for antitubercular activity.  Compounds IV c, IV f, IV h and IV o showed significant antitubercular activity.

Full text article

Generated from XML file

Authors

Neha Krishnarth
nkrishnarth@gmail.com (Primary Contact)
Santosh Kumar Verma
Anurag
Neha Krishnarth, Santosh Kumar Verma, & Anurag. (2019). Quinazolinone novel derivatives synthesis and their Biological Evaluation as Antimicrobial and Antitubercular agents. International Journal of Research in Pharmaceutical Sciences, 10(4), 3025–3033. Retrieved from https://ijrps.com/home/article/view/2936

Article Details

No Related Submission Found